We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Martin Marietta Materials
MLM
$33.6B
| $8.17M | 0.11% |
58,457
+55,665
| +1,994% | +$7.15M |
|
|
BPFH
227
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $8.17M | 0.11% |
+672,388
| New | +$8.27M |
|
228
Lam Research
LRCX
$382B
| $8.14M | 0.11% |
+1,159,690
| New | +$9.17M |
|
|
AOL
229
DELISTED
AOL INC COMMON STOCK
AOL
| $8.11M | 0.11% |
+204,628
| New | +$8.77M |
|
|
XLNX
230
DELISTED
Xilinx Inc
XLNX
| $8.1M | 0.11% |
191,428
-317,213
| -62% | -$13M |
|
231
Incyte
INCY
$23.5B
| $8.07M | 0.11% |
+88,015
| New | +$7.28M |
|
|
JOYY
232
JOYY Inc
JOYY
$3.73B
| $8.05M | 0.1% |
147,597
+44,699
| +43% | +$2.78M |
|
233
Acadia Healthcare
ACHC
$3.17B
| $7.93M | 0.1% |
110,703
-5,030
| -4% | -$323K |
|
|
RCPT
234
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $7.92M | 0.1% |
48,065
-4,298
| -8% | -$544K |
|
235
Cboe Global Markets
CBOE
$29.8B
| $7.89M | 0.1% |
137,413
-183,693
| -57% | -$11.4M |
|
236
SiriusXM
SIRI
$10B
| $7.88M | 0.1% |
206,189
-110,970
| -35% | -$4.16M |
|
|
LQ
237
DELISTED
La Quinta Holdings Inc.
LQ
| $7.85M | 0.1% |
331,686
+28,030
| +9% | +$620K |
|
238
American International
AIG
$41.9B
| $7.8M | 0.1% |
+142,282
| New | +$7.63M |
|
239
Merck
MRK
$324B
| $7.77M | 0.1% |
141,673
-179,019
| -56% | -$10.1M |
|
240
United Airlines
UAL
$38.4B
| $7.73M | 0.1% |
114,960
+96,016
| +507% | +$6.51M |
|
241
Cirrus Logic
CRUS
$6.74B
| $7.62M | 0.1% |
229,161
-446,574
| -66% | -$13M |
|
242
Ultragenyx Pharmaceutical
RARE
$2.65B
| $7.61M | 0.1% |
+122,613
| New | +$6.81M |
|
243
Burlington
BURL
$22B
| $7.57M | 0.1% |
127,359
-155,100
| -55% | -$8.32M |
|
244
Delta Air Lines
DAL
$55.9B
| $7.55M | 0.1% |
167,969
+154,998
| +1,195% | +$7.19M |
|
245
AbbVie
ABBV
$458B
| $7.54M | 0.1% |
+128,861
| New | +$7.78M |
|
|
OMG
246
DELISTED
OM GROUP INC.
OMG
| $7.48M | 0.1% |
+249,065
| New | +$7.24M |
|
|
MXIM
247
DELISTED
Maxim Integrated Products
MXIM
| $7.36M | 0.1% |
211,512
+149,612
| +242% | +$5.11M |
|
248
ManpowerGroup
MAN
$2.39B
| $7.28M | 0.09% |
84,517
-237,952
| -74% | -$18.1M |
|
249
Graphic Packaging
GPK
$3.26B
| $7.21M | 0.09% |
495,572
-154,623
| -24% | -$2.26M |
|
250
AstraZeneca
AZN
$263B
| $7.19M | 0.09% |
+105,061
| New | +$7.3M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.